Physician profile
Amber Jo Anderson
NPI 1043772189
$34,326.00
in general payments reported to CMS, 2019-2025
12 companies · $4,079 in 2025
The $4,079 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,262 · 2020: $1,943 · 2021: $2,423 · 2022: $1,366 · 2023: $354 · 2024: $22K · 2025: $4,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $24K · Food and Beverage: $1,160 · Travel and Lodging: $1,076 · Education: $96.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $24,000.00 |
| Food and Beverage | $1,159.68 |
| Travel and Lodging | $1,076.08 |
| Education | $96.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $20,308.08 | 2024-2025 | |
| Rock Medical Orthopedics, INC. | $7,843.77 | 2019-2022 | |
| Smith+Nephew, INC. | $5,170.96 | 2023-2025 | Real Intelligence, Legion Revision, Evos |
| Stryker Corporation | $447.26 | 2022-2025 | T2 Alpha, Ortholoc 3di, Pro |
| Zimmer Biomet Holdings, INC. | $116.53 | 2024 | |
| Convatec INC. | $111.57 | 2023 | |
| Si-Bone, INC. | $98.24 | 2024 | |
| Pinnacle, INC | $83.26 | 2025 | |
| Vericel Corporation | $50.00 | 2025 | Maci |
| Depuy Synthes Sales INC. | $44.91 | 2025 | Vapr, Dynacord |
| Medtronic, INC. | $35.43 | 2023 | Aquamantys(Tm) |
| Vertex Pharmaceuticals Incorporated | $15.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.